Search

Displaying results 7231 - 7240 of 9314 in total
  1. Drug

    Esreboxetine

    go.drugbank.com/drugs/DB12395
    Investigational

    Esreboxetine has been used in trials studying the treatment and basic science of Fibromyalgia.

  2. Drug

    PF-03635659

    go.drugbank.com/drugs/DB12408
    Investigational

    Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.

  3. Drug

    Lifibrol

    go.drugbank.com/drugs/DB12448
    Investigational

    Lifibrol has been used in trials studying the basic science of Hyperlipoproteinemia and Hypercholesterolemia.

  4. Drug

    Imeglimin

    go.drugbank.com/drugs/DB12509
    Investigational

    Imeglimin has been used in trials studying the treatment of Type 2 Diabetes Mellitus.

  5. Drug

    MK-5108

    go.drugbank.com/drugs/DB12556
    Investigational

    MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors.

  6. Drug

    4SC-203

    go.drugbank.com/drugs/DB12669
    Investigational

    4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.

  7. Drug

    Tedisamil

    go.drugbank.com/drugs/DB06200
    Experimental

    It is currently being developed by Solvay and is currently under regulatory review by the United States Food and Drug Administration.

  8. Drug

    Latrunculin A

    go.drugbank.com/drugs/DB02621
    Investigational

    Latrunculin A is an actin binding macrolide purified from the red sea sponge Latrunculia magnifica. It is under investigation for the treatment of cancer.

    Synonyms: (4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one
  9. Drug

    MVR-T3011

    go.drugbank.com/drugs/DB17378
    Investigational

    MVR-T3011 is a genetically modified oncolytic Herpes Simplex Virus (HSV-1) with 2 exogenous genes encoding the active heterodimer human interleukin 12 (IL-12) and the Fab fragment of an anti-human PD-1

  10. Drug

    Dendritic cells vaccine

    go.drugbank.com/drugs/DB15803
    Investigational

    With a better safety profile than inactivated and live-attenuated virus and virus-vector vaccines, the recombinant chimeric DC vaccine reduces the risk of virulence recovery, pre-existing anti-vector immunity … The recombinant chimeric DC vaccine is a subunit-based vaccine candidate investigated for safety and effectiveness against SARS-CoV-2-induced pneumonia.